AmInvest Research Reports

Ancom Nylex - Prospects still bright despite ASP dip

AmInvest
Publish date: Wed, 19 Apr 2023, 09:50 AM
AmInvest
0 8,756
An official blog in I3investor to publish research reports provided by AmInvest research team.

All materials published here are prepared by AmInvest. For latest offers on AmInvest trading products and news, please refer to: https://www.aminvest.com/eng/Pages/home.aspx

Tel: +603 2036 1800 / +603 2032 2888
Fax: +603 2031 5210
Email: enquiries@aminvest.com

Office Hours
Monday to Thursday: 8:45am – 5:45pm
Friday: 8:45am – 5:00pm
(GMT +08:00 Malaysia)

Investment Highlights

  • We maintain our BUY call on Ancom Nylex (Ancom) with an unchanged fair value (FV) of RM1.43/share. This is pegged to an unchanged target FY24F PE of 14x, 0.75 standard deviation (SD) below its 5-year mean of 21x. No ESG-related FV adjustment based on an unchanged 3-star rating.
  • Pending an analyst briefing later today, we maintain our earnings forecasts for now as Ancom’s 9MFY23 core net profit of RM58.2mil generally came in within our expectation, accounting for 74% of our FY23F net profit, but slightly above consensus, accounting for 78% of consensus.
  • No interim dividend has been declared in this quarter, which is in line with our blank FY23F-FY25F assumption as the group remains on a capex-driven expansionary trajectory to introduce new product lines.
  • On a YoY basis, Ancom’s 3QFY23 revenue registered a decline of 5% to RM484mil from RM510mil in 3QFY22. Consequently, 3QFY23 core net profit decreased by 2% to RM15.9mil from RM16.1mil in 3QFY22. The weaker earnings were mostly related to the industrial chemicals segment, which experienced lower revenue (-19% YoY) and EBIT margin of 1.6% (-0.8ppt YoY) owing to lower average selling prices (ASP).
  • On a QoQ basis, Ancom’s 3QFY23 core net profit decreased by 30%, in tandem with a 9% contraction in revenue. The weaker revenue was primarily attributed to agrichemical (-24% QoQ) and industrial chemical (-10% QoQ) segments, while the earnings decline was solely due to agrichemicals.
  • The agrichemicals segment experienced a decrease in ASP as a result of falling crude oil prices (-9% QoQ), while sales volume was unchanged.
  • Separately, the industrial chemicals segment experienced a decline in both ASP and sales volume amid lower crude oil prices and weaker global economic activities. Nevertheless, oil prices remained stable post-3QFY23.
  • Notably, industrial chemical EBIT improved by 16% QoQ, mainly driven by a greater contribution from higher-margin manufacturing segment, particularly the ethanol segment.
  • Going forward, we expect the agrichemical segment to be slightly weaker in 4QFY23 due to lower sales volume which could be impacted by crop prices (-2% QoQ). However, the industrial chemicals segment should be stronger on higher ASP and stable sales volume, based on our unchanged oil price forecast of US$80-90/barrel for 2023 compared to the average oil price in March 2023 of US$80/barrel.
  • In the near term, we believe Ancom’s revenue prospects will continue to benefit from the ban on paraquat, especially in Thailand and Malaysia. Over the medium-to-long term, the introduction of new active agrichemical ingredients will further underpin the upward trajectory of the group’s FY23F-25F earnings.
  • The stock currently trades at an unjustified FY24F PE of 11x, half of its 5-year mean of 21x, for the largest agrichemical manufacturer in ASEAN.

Source: AmInvest Research - 19 Apr 2023

Related Stocks
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment